Bausch & Lomb Corp (NYSE:BLCO)
$ 16.16 +0.18 (+1.16%) Market Cap: 5.76 Bil Enterprise Value: 10.63 Bil PE Ratio: 0 PB Ratio: 0.93 GF Score: 77/100

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 09:30PM GMT
Release Date Price: $17.5 (+1.69%)
Robbie Marcus
JPMorgan Chase & Co - Analyst

Good afternoon, everyone. I hope you enjoyed your lunch. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to present our next speaker, Brent Saunders, the CEO of Bausch + Lomb. Brent will do a presentation followed by some Q&A.

Brent?

Brenton Saunders;Lomb Corp;Chairman of the Board
Bausch;Chief Executive Officer

+- -

Good afternoon, and thank you for joining us here today. The JPMorgan Healthcare Conference brings together companies that are not only competing in health care, but shaping where the industry is going and we're very proud to be part of the conversation. Special thank you, Robbie, for hosting us here today.

As we shared at our Investor Day in November, we are transforming Bausch + Lomb with a clear strategy, disciplined execution and a relentless focus on innovation grounded in patient needs. The world's demand for eye health solution continues to grow, and we believe we are uniquely positioned to meet it through the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot